PARKER CHARLES NOLAN (Chief Financial Officer) received a stock award from TRAWS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/8/2026ACC: 0002125562-26-000004
Officer· Chief Financial Officer
Since Jul 2025
+213.91K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
213.91K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.39K
Price / share
—
Trade value
—
% of position
New position
12/12/2025
0.00→15.39K
Total
Net shares
+15.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | A · Award | +15.39K | — | — | New position | 0.00 | 15.39K |
| Total | +15.39K | $0.00 | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
32.41K shares
Shares
+32.41K
Strike price
3.01
Held after
32.41K
Exercisable
—
10/12/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
61.57K shares
Shares
+61.57K
Strike price
2.33
Held after
61.57K
Exercisable
—
12/12/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
104.54K shares
Shares
+104.54K
Strike price
1.60
Held after
104.54K
Exercisable
—
3/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock32.41K shares | 10/12/2025 | A · Award | +32.41K | 3.01 | — | 32.41K |
| Stock Option (right to buy) Direct | Common Stock61.57K shares | 12/12/2025 | A · Award | +61.57K | 2.33 | — | 61.57K |
| Stock Option (right to buy) Direct | Common Stock104.54K shares | 3/8/2026 | A · Award | +104.54K | 1.60 | — | 104.54K |